Daewoong pharmaceutical

069620.KO

76.11 USD

-1.62

-2.08%

Overview

Last close

76.11 usd

Market cap

875.72M usd

52 week high

134.42 usd

52 week low

69.90 usd

Target price

140.83 usd

Valuation

P/E

6.1218

Forward P/E

N/A

Price/Sales

0.7149

Price/Book Value

1.1247

Enterprise Value

1.47B usd

EV/Revenue

1.2006

EV/EBITDA

7.4995

Key financials

Revenue TTM

1.22B usd

Gross Profit TTM

640.20M usd

EBITDA TTM

192.38M usd

Earnings per Share

12.73 usd

Dividend

0.45 usd

Total assets

1.64B usd

Net debt

496.50M usd

About

Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices. The company was founded in 1945 and is headquartered in Seoul, South Korea.